A Closer Look: Renal Artery Stenosis. Renal artery stenosis (RAS) is defined as a TOPICS FROM CHEP. Shawn s stenosis
|
|
- Wilfred Sims
- 5 years ago
- Views:
Transcription
1 TOPICS FROM CHEP A Closer Look: Renal Artery Stenosis On behalf of the Canadian Hypertension Education Program (CHEP), Dr. Tobe gives an overview of renal artery stenosis, including the prevalence, screening techniques, management and treatment options for this serious disease. Sheldon W. Tobe, MD, FRCPC; on behalf of the Canadian Hypertension Education Program Renal artery stenosis (RAS) is defined as a narrowing of the lumen of the renal artery. 1 Atherosclerotic renovascular disease is a combination of RAS and renal ischemia. 2 The disease may be unilateral or bilateral (or unilateral in the setting of one kidney). Atherosclerotic renovascular disease occurring in the elderly is most often due to atherosclerosis, which, because of its systemic nature, Copyright most often leads to disease of both large and small arteries of both kidneys. Progressive impairment in renal function occurs through ischemia of affected areas and hypertensive damage to the parts of the kidney perfused by relatively normal renal arteries. Fibromuscular disease, mostly found in younger female patients that smoke, responds well to angioplasty without stenting but is not reviewed here. Ischemic nephropathy describes the reduction in glomerular filtration rate (GFR) that is caused by hemodynamically significant RAS. Thus, a patient with atherosclerotic renovascular disease has both large and small vessel arterial disease and often has a loss of GFR due to ischemic nephropathy. Although renal artery atherosclerosis is common, as is atherosclerosis in the general adult population, renal perfusion is not reduced until there is > 50% stenosis and BP does not usually rise until the RAS is 60% to 70%. 2 Shawn s stenosis Shawn, 54, is transferred from a rural hospital for urgent renal artery revascularization after presenting in a hypertensive crisis. Magnetic resonance (MR) angiography identified a critical stenosis of the left renal artery as well as an 80% stenosis in the right renal artery. Diffuse atherosclerosis was noted. Shawn had not had his BP measured in decades, his ECHO showed evidence of left ventricular hypertrophy (LVH) and he had a long history of smoking. On arrival, Shawn was on four antihypertensives and: his BP was controlled to < 140/90 mmhg, his creatinine was 135 µmol/l and he was comfortable. Not for Sale or Commercial Distribution Unauthorised use prohibited. Authorised users can download, display, view and print a single copy for personal use Shawn wants to know the following: Could he have been diagnosed earlier? What medical therapy is necessary? What is the natural history of this disease without medical or radiological intervention? What should his target BP be? Can percutaneous revascularization procedures allow him to reduce his medications and bring his BP under better control? Which of these revascularization procedures would be best for him? Will these procedures help preserve his renal function and/or prevent cardiovascular disease? For the answers to these questions, turn to page Perspectives in Cardiology / September
2 In most patients with atherosclerotic renovascular disease, there is disease in both kidneys. Risk factors for atherosclerotic RAS include: long-standing hypertension, diabetes, smoking and dyslipidemia. These are also risk factors for premature coronary artery disease. Table 1 Factors associated with lower likelihood of response to renal revascularization Urinary protein excretion >1 g/d Hyperuricemia GFR < 40 ml/min Age > 65 years Pulse pressure of at least 70 mmhg Diastolic BP < 80 mmhg, systolic BP < 160 mmhg Male gender No abrupt elevation in BP Duration of hypertension > 10 years Diabetes mellitus No history of smoking Coronary artery disease Cerebrovascular disease Peripheral arterial disease The prevalence of atherosclerotic renovascular disease is approximately 1% of the hypertensive population. Prevalence The prevalence of atherosclerotic renovascular disease is approximately 1% of the hypertensive population. 2 In a group of people > 65-years-ofage, atherosclerotic renovascular disease diagnosed by Doppler ultrasound was found in 6.8%. 3 In patients with hypertension resistant to two medications, the prevalence was found to be 20%. 4 While RAS is prevalent in hypertension particularly in patients complicated by other atherosclerotic disease, the presence of the anatomical renal artery narrowing is not always associated with hypertension. This may explain one of the reasons why renal revascularization does not lower BP in all patients with atherosclerotic renovascular disease. Screening The ideal single screening test for atherosclerotic renovascular disease would: be accurate, have low technical failure, have high sensitivity and specificity and be non-invasive as well as inexpensive. 5,6 Magnetic resonance angiography (MRA) and CT angiography are non-invasive and have a high sensitivity and specificity, but have high costs and carry a risk for acute renal dysfunction related to the dyes that are used (contrast media for CT scan and radiation exposure or gadolinium for MRA). MRA is also contraindicated for patients with claustrophobia, metallic implants, obesity or for the seriously ill. The captopril-enhanced renal scan has lower sensitivity and specificity in patients with reduced renal function. 7 Doppler ultrasonography has been demonstrated 28 Perspectives in Cardiology / September 2007
3 to have high sensitivity and specificity in experienced hands for the diagnosis of anatomical lesions. 5 It can also detect unilateral and bilateral lesions, accessory renal arteries, is noninvasive and inexpensive. Obesity, excessive bowel gas or poor blood flow in the main renal artery can interfere with direct visualization. The renal resistance index (RRI) performed as part of a Doppler ultrasound exam is a powerful tool for identifying patients that may not benefit from revascularization. It is easy to learn and can effectively be applied to all patients referred for a simple abdominal ultrasound as part of the initial investigation for atherosclerotic renal arterial disease. Predicting patient outcomes Simple measurements of serum renin levels have been investigated to predict the potential success of surgical revascularization, but the frequency of false-negative and false-positive results make this screening test unhelpful. 8 Even when the accuracy of the serum renin test is enhanced by the addition of an ACE inhibitor, the test still has insufficient specificity and sensitivity to be recommended. 9 Also, renin-based diagnostic tests are limited by antihypertensive drugs that interfere with plasma renin activity. The best determinant of patient outcome is not the degree of RAS but the degree of renal function. Damage to the nephrons has been found to be more important in the pathogenesis of renal dysfunction than the degree of the renal artery stenosis. 10 Renal revascularization has not been shown to be associated with improved patient survival or even renal survival compared to medical therapy alone. 11 However, with medical management alone, the progression to total renal artery occlusion occurs at about 3% to 5% per year, but only in those with > 60% stenosis. 12 Table 2 Clues suggesting the need for assessment of renovascular hypertension Patients presenting with 2 of the clinical clues listed below, suggesting renovascular hypertension, should be investigated. Sudden onset or worsening of hypertension and age > 55 or < 30 years The presence of an abdominal bruit Hypertension resistant to 3 drugs A rise in creatinine associated with the use of an ACE inhibitor or ARB Other atherosclerotic vascular diseases, particularly in patients who smoke or have dyslipidemia Recurrent pulmonary edema associated with hypertensive surges Shawn s case cont d... Shawn recognizes that renovascular disease is a marker for cardiovascular risk and focuses on risk reduction strategies, including lifestyle, modification and medication changes. His target systolic BP is < 140 mmhg, if tolerated. He is started on high-dose statin therapy. Although his BP is controlled and his renal function is stable, he elects to have revascularization and bilateral renal stents are put into place. He is able to stop one of his antihypertensives. On return home, he remains on his medications and his BP remains well controlled. Dr. Tobe is an Associate Professor of Medicine, University of Toronto and the Director of Home Dialysis, Division of Nephrology, Sunnybrook Health Science Centre, Toronto, Ontario. Perspectives in Cardiology / September
4 Table 3 Recommendations for the management of hypertension in atherosclerotic renovascular disease Renovascular hypertension should be treated in the same manner as uncomplicated hypertension, except for caution in the use of ACE inhibitors or ARBs due to the risk of acute renal failure in bilateral disease or unilateral disease with a solitary kidney Close follow-up and early intervention (angioplasty and stenting or surgery) should be considered for patients with: - uncontrolled hypertension despite therapy with 3 drugs, - deteriorating kidney function, - bilateral atherosclerotic renal artery lesions (or tight atherosclerotic stenosis in a single kidney), or - recurrent episodes of flash pulmonary edema Alternatives to surgery Angiographic endovascular procedures are increasingly replacing surgery for the revascularization of atherosclerotic renovascular disease. 13 A meta-analysis of these studies of renal revascularization without stenting was able to show an 8 mmhg reduction in BP but could not show improvement in renal function compared to conservative strategies. 14 For factors associated with a lower likelihood of response to revascularization see Table 1. Percutaneous renal angioplasty (PTRA) with stenting has led to higher rates of successful revascularization (> 80%) and lower restenosis rates (< 20%) than revascularization without stenting. 15 In general, studies of PTRA for atherosclerotic renovascular disease have shown that renal function in patients is improved in about 25%, stabilizes in approximately 40%, but worsens in about 25%. 16 An approach to atherosclerotic renovascular disease must recognize that some patients have anatomical RAS with no functional effect, while others have both and still others have stenosis causing hypertension or loss of renal function renal disease. Because of microvascular disease within the affected kidney, even if the stenosis was repaired, these problems would not be resolved. Revascularization, by angioplasty and stent insertion, should be considered for patients with uncontrollable hypertension or deteriorating renal function (Table 2). For those with a high likelihood of atherosclerotic renovascular disease, the following tests are recommended, when available, to screen for renal artery stenosis: Renovascular disease Does not imply specific treatment choice Caution in the use of ACE inhibitor/arb in bilateral renal artery stenosis or unilateral disease with solitary kidney Figure 1. Treatment of hypertension in patients with renovascular disease. 30 Perspectives in Cardiology / September 2007
5 captopril-enhanced radioisotope renal scan (if GFR > 60 ml/minute), Doppler sonography, MRA and CT angiography. The optimal test for diagnosing renovascular hypertension depends on local radiological expertise and the underlying clinical situation. The prevalence of atherosclerotic renovascular disease is approximately 1% of the hypertensive population. Management of hypertension The management of hypertension in this condition involves the use of combinations of antihypertensive agents at doses sufficient to control BP. Blockers of the renin-angiotensinaldosterone system must be used with close monitoring of renal function and serum potassium levels, preferably with an existing baseline result and another within a week or so of initiating therapy. Diuretics and long-acting calcium channel blockers are common mainstays of therapy. Medical management also includes aggressive lipid-lowering therapy with high-dose statin therapy, or possibly, the combination of a lower dose statin in the setting of chronic kidney disease and a cholesterol absorption inhibitor drug such as ezetimibe, the use of antiplatelet therapy, smoking cessation, as well as diet and lifestyle counselling. The recommendations for the management of hypertension in atherosclerotic renovascular disease are found in Table 3. PCard References 1. Rundback JH, Sacks D, Kent KC, et al: Guidelines for the Reporting of Renal Artery Revascularization in Clinical Trials. J Vasc Interv Radiol 2002; 13(10): Pickering TG, Blumenfeld JD: Renovascular Hypertension and Ischemic Nephropathy. In: Brenner BM (ed): Brenner and Rector s The Kidney. W.B Saunders Co, Philadelphia: 2000, pp Hansen KJ, Edwards MS, Craven TE, et al: Prevalence of Renovascular Disease in the Elderly: A Population-Based Study. J Vasc Surg 2002; 36(3): van Jaarsveld BC, Krijnen P, Derkx FH, et al: Resistance to Antihypertensive Medication as Predictor of Renal Artery Stenosis: Comparison of Two Drug Regimens. J Hum Hypertens 2001; 15(10): Radermacher J, Chavan A, Schaffer J, et al: Detection of Significant Renal Artery Stenosis with Color Doppler Sonography: Combining Extrarenal and Intrarenal Approaches to Minimize Technical Failure. Clinical Nephrology 2000; 53(5): Radermacher J, Chavan A, Bleck J, et al: Use of Doppler Ultrasonography to Predict the Outcome of Therapy for Renal-Artery Stenosis. NEJM 2001; 344(6): Taylor A: Functional Testing: ACEI Renography. [Review] [51 refs]. Seminars in Nephrology 2000; 20(5): Radermacher J, Haller H: The Right Diagnostic Work-Up: Investigating Renal and Renovascular Disorders. [Review] [22 refs]. J Hypertens 2003; 21(Suppl2):S19-S Lenz T, Kia T, Rupprecht G, et al. Captopril Test: Time Over? J Hum Hypertens 1999; 13(7): Wright JR, Shurrab AE, Cheung C, et al: A Prospective Study of the Determinants of Renal Functional Outcome and Mortality in Atherosclerotic Renovascular Disease [comment]. Am J Kidney Dis 2002; 39(6): Losito A, Errico R, Santirosi P, et al: Long-Term Follow-up of Atherosclerotic Renovascular Disease. Beneficial effect of ACE Inhibition. Nephrol Dial Transplant 2005; 20(8): Caps MT, Perissinotto C, Zierler RE, et al: Prospective Study of Atherosclerotic Disease Progression in the Renal Artery. Circulation 1998; 98(25): Mackrell PJ, Langan EM III, Sullivan TM, et al: Management of Renal Artery Stenosis: Effects of a Shift from Surgical to Percutaneous Therapy on Indications and Outcomes. Ann Vasc Surg 2003; 17(1): Nordmann AJ, Woo K, Parkes R, et al: Balloon Angioplasty or Medical Therapy for Hypertensive Patients with Atherosclerotic Renal Artery Stenosis? A Meta-Analysis of Randomized Controlled Trials. American J of Medicine 2003; 114(1): Leertouwer TC, Gussenhoven EJ, Bosch JL, et al: Stent Placement for Renal Arterial Stenosis: Where Do We Stand? A Meta-Analysis. Radiology 2000; 216(1): Textor SC, Wilcox CS: Renal Artery Stenosis: A Common, Treatable Cause of Renal Failure? [Review] [127 refs]. Ann Rev Med 2001; 52: Perspectives in Cardiology / September
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationRenal artery stenosis
Renal artery stenosis Dr. Alexander Woywodt Consultant Renal Physician, Royal Preston Hospital Preston, 31.10.2007 Menu anatomy of the renal arteries diseases of the large renal arteries atherosclerotic
More informationDisclosure of Potential Conflicts. Renal Artery Stenosis. RAS Epidemiology. Road Map. Background. ASDIN 7th Annual Scientific Meeting
Renal Artery Stenosis Disclosure of Potential Conflicts Cytopherx, Inc. R4 Vascular, Inc. Bard Peripheral Vascular Spectranetics, Inc. Alexander S. Yevzlin, MD Associate Professor of Medicine (CHS) ASDIN
More informationAtherosclerotic Renovascular Hypertension : Lessons from Recent Clinical Studies
Review ISSN 1738-5997 (Print) ISSN 2092-9935 (Online) Electrolyte Blood Press 8:87-91, 2010 doi: 10.5049/EBP.2010.8.2.87 Atherosclerotic Renovascular Hypertension : Lessons from Recent Clinical Studies
More informationRAS Epidemiology. Renal Artery Stenosis. Pathophysiology of RAS. Disclosure of Potential Conflicts. Background Pathophysiology of RAS.
Renal Artery Stenosis RAS Epidemiology Common Disease Incidence General Population 0.1% Hypertensive Population 4% HTN & Suspected CAD 10-20% Malignant HTN 20-30% Malignant HTN and CKD 30-40% Alexander
More informationLife After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention
Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention No Relationships to Disclose The Need for Modern Renal Trials Increased rate of RAS diagnosis
More informationRenal Artery Stenting
Renal Artery Stenting J.P. Reilly, MD, FSCAI Ochsner Medical Center Speaker s bureau: Astra Zeneca and Lilly/Diachi Sankyo Prevalence of RAS is high in cath population. Renal artery intervention can help
More informationNatural history and progression of atherosclerotic renal vascular stenosis
204..209 NEPHROLOGY 2010; 15, S204 S209 doi:10.1111/j.1440-1797.2009.01242.x Natural history and progression of atherosclerotic renal vascular stenosis Date written: December 2008nep_1242 Final submission:
More informationDuplex Ultrasound of the Renal Arteries. Duplex Ultrasound. In the Beginning
Duplex Ultrasound of the Renal Arteries DIMENSIONS IN HEART AND VASCULAR CARE 2013 PENN STATE HEART AND VASCULAR INSTITUTE ROBERT G. ATNIP MD PROFESSOR OF SURGERY AND RADIOLOGY Duplex Ultrasound Developed
More informationEffective Health Care
Number 5 Effective Health Care Comparative Effectiveness of Management Strategies for Renal Artery Stenosis Executive Summary Background Renal artery stenosis (RAS) is defined as the narrowing of the lumen
More informationAtherosclerotic renovascular disease
Cardiology 69 Atherosclerotic renal artery stenosis Atherosclerotic renal artery stenosis is largely a disease of the elderly and is commonly associated with hypertension and renal dysfunction. Blood pressure
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationDr Doris M. W Kinuthia
Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of
More informationPeripheral Arterial Disease: Who has it and what to do about it?
Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%
More informationNOT FOR PUBLICATION, QUOTATION, OR CITATION RESOLUTION NO. 22
BE IT RESOLVED, Sponsored By: RESOLUTION NO. 22 that the American College of Radiology adopt the ACR SIR Practice Parameter for the Performance of Angiography, Angioplasty, and Stenting for the Diagnosis
More informationDiagnosis of Renal Artery Stenosis (RAS)
May 2001 Diagnosis of Renal Artery Stenosis (RAS) Kurt Fink, Harvard Medical School, Year III Epidemiology Hypertension -Affects 60 million Americans Essential HTN >95% of cases Secondary HTN 1-5% of cases
More informationRenal Artery Disease. None > 65,000,000. Learning objectives: Renal Artery Disease
Renal Artery Disease Robert D. McBane, M.D. Division of Cardiology Mayo Clinic Rochester Financial Disclosure Information Renal Artery Disease Robert McBane, MD None To appreciate: Learning objectives:
More informationKEY WORDS: Bilateral Renal Artery Stenosis, Cardiac Catherization, Incidental Findings, Associated Co- morbidity
BILATERAL RENAL ARTERY STENOSIS - AN INCIDENTAL FINDING DURING CARDIAC CATHETERIZATION Review of 15 Cases of BRAS Stenting at Queen Alia Heart Institute in Jordan Hatem Hamdan Salaheen Abbadi 1 ABSTRACT:
More informationIschemic nephropathy: Detection and therapeutic intervention
Kidney International, Vol. 68, Supplement 99 (2005), pp. S131 S136 Ischemic nephropathy: Detection and therapeutic intervention JOSÉ A. GARCíA-DONAIRE and JOSÉ M. ALCÁZAR Department of Nephrology, Hospital
More informationEndovascular treatment
210..217 NEPHROLOGY 2010; 15, S210 S217 doi:10.1111/j.1440-1797.2009.01243.x Endovascular treatment Date written: February 2009nep_1243 Final submission: August 2009 Authors: Robert MacGinley, Subramanian
More informationRENAL ARTERY PTA. JH PEREGRIN IKEM, Prague
RENAL ARTERY PTA JH PEREGRIN IKEM, Prague PTRA/Stenting PTRA technical success rate > 90 % In some patients helps control hypertension In some patients can improve kidney function Serious complications
More informationRenal Artery Stenosis: Insights from the CORAL Trial
Renal Artery Stenosis: Insights from the CORAL Trial Christopher J. Cooper, M.D., FACC, FACP Dean and Senior Vice President University of Toledo, College of Medicine President, Ohio Chapter ACC State of
More informationMichael Meuse, M.D. Vascular and Interventional Radiology
Michael Meuse, M.D. Vascular and Interventional Radiology Which patient would likely benefit from renal artery revascularization? Patient A- 60 y/o male with 20 year hx of htn; on 2 drug therapy for 10
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationAtherosclerotic renal artery stenosis and reconstruction
http://www.kidney-international.org & 2006 International Society of Nephrology mini review Atherosclerotic renal artery stenosis and reconstruction B Krumme 1 and J Donauer 2 1 Deutsche Klinik für Diagnostik,
More informationRenovascular hypertension in children and adolescents
Renovascular hypertension in children and adolescents M I E C Z Y S L AW L I T W I N D E P T. O F N E P H R O LO G Y & A R T E R I A L H Y P E R T E N S I O N T H E C H I L D R E N S M E M O R I A L H
More informationThe Struggle to Manage Stroke, Aneurysm and PAD
The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology
More informationEvidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationGrand Rounds. Renal Artery Disease: Diagnosis and Management. Abstract
Grand Rounds Renal Artery Disease: Diagnosis and Management JEFFREY W. OLIN, D.O. Abstract Renal artery stenosis (RAS) is most commonly due to either fibromuscular dysplasia or atherosclerosis. The former
More informationRenal artery stenosis is the most common cause of secondary hypertension. Over 90% of renal
General cardiology ARTERIOSCLEROTIC RENAL ARTERY STENOSIS: CONSERVATIVE VERSUS INTERVENTIONAL MANAGEMENT c RENAL Additional references appear on the Heart website Correspondence to: Priv. Doz. Dr C Haller,
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationDeakin Research Online
Deakin Research Online This is the published version: MacGinley, Rob and Mangos, George 2010, Renal artery stenosis and hypertension: whom and how to screen and treat, Medicine today, vol. 11, no. 2, pp.
More informationIncidence and Prevalence of Atherosclerotic Renal Artery Stenosis (RAS) in Patients with Coronary Artery Disease (CAD)
Incidence and Prevalence of Atherosclerotic Renal Artery Stenosis (RAS) in Patients with Coronary Artery Disease (CAD) AHMW Islam, S Munwar, S Talukder, AQM Reza Dept. of Invasive & Interventional Cardiology,
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute myocardial infarction contemporary DES platforms in patients with, 290 AF. See Atrial fibrillation (AF) African Americans dietary factors
More informationImmediate Normalisation of Blood Pressure following Intervention in Functional Total Occlusion of Unilateral Renal Artery with an Atrophic Kidney
Immediate Normalisation of Blood Pressure following Intervention in Functional Total Occlusion of Unilateral Renal Artery with an Atrophic Kidney Dr Parminder Singh Otaal Assistant Professor Department
More informationNoninvasive cardiac imaging refers
CARDIOLOGY PATIENT PAGE Introduction to Noninvasive Cardiac Imaging Ron Blankstein, MD Noninvasive cardiac imaging refers to a combination of methods that can be used to obtain images related to the structure
More informationCORAL Trial Aftermath: What Do We Do Now? Renal Revascularization in Perspective
CORAL Trial Aftermath: What Do We Do Now? Renal Revascularization in Perspective Michael R. Jaff, DO Massachusetts General Hospital Boston, Massachusetts, USA Michael R. Jaff, DO Conflicts of Interest
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationManagement of early chronic kidney disease
Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown
More informationCaptopril test: time over?
ORIGINAL ARTICLE Journal of Human Hypertension (1999) 13, 431 435 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh T Lenz 1, T Kia 1, G Rupprecht 1, K-L
More informationCoral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.
Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico
More informationChronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
More informationHYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL
HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationStages of Chronic Kidney Disease (CKD)
Early Treatment is the Key Stages of Chronic Kidney Disease (CKD) Stage Description GFR (ml/min/1.73 m 2 ) >90 1 Kidney damage with normal or GFR 2 Mild decrease in GFR 60-89 3 Moderate decrease in GFR
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationImaging for Peripheral Vascular Disease
Imaging for Peripheral Vascular Disease James G. Jollis, MD Director, Rex Hospital Cardiovascular Imaging Imaging for Peripheral Vascular Disease 54 year old male with exertional calf pain in his right
More informationCase yr old lady; type 2 Diabetes 10 yrs; PVD; hypertension
Does this patient have flash pulmonary oedema? Philip A Kalra Professor of Nephrology, Salford Royal Hospital and University of Manchester, UK 73 yr old lady; type 2 Diabetes 1 yrs; PVD; hypertension Acute
More informationThe role of percutaneous revascularization for renal artery stenosis
The role of percutaneous revascularization for renal artery stenosis Gregory J Dubel and Timothy P Murphy Abstract: Renal artery stenosis (RAS) is usually caused by atherosclerosis or fibromuscular dysplasia.
More information21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease
21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,
More informationHow to assess the hemodynamic importance of a renal artery stenosis. Felix Mahfoud, MD Saarland University Hospital Homburg/Saar, Germany
How to assess the hemodynamic importance of a renal artery stenosis Felix Mahfoud, MD Saarland University Hospital Homburg/Saar, Germany How to assess renal artery stenosis severity 1. Non-invasive assessments
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More informationHypertension Update Background
Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationWhat s New? Hypertension Canada Guidelines for the Management of Hypertension
What s New? 2017 Hypertension Canada Guidelines for the Management of Hypertension What s New? About This Booklet This booklet highlights key advancements and important, enduring aspects of the Hypertension
More informationOutcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting
Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting Xue F Y, Bettmann M A, Langdon D R, Wivell W A Record Status
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationUS of Renovascular Hypertension. Jonathan R. Dillman, MD, MSc Associate Professor Director, Thoracoabdominal Imaging
US of Renovascular Hypertension Jonathan R. Dillman, MD, MSc Associate Professor Director, Thoracoabdominal Imaging Disclosures Nothing Relevant Unrelated grant funding Siemens US Toshiba US Objectives
More informationORIGINAL ARTICLE. Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian Medical University, Katowice, Poland
ORIGINAL ARTICLE Cardiology Journal 2009, Vol. 16, No. 6, pp. 514 520 Copyright 2009 Via Medica ISSN 1897 5593 Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with
More informationav ailab le at jou rn al h om epa g e:
Journal of Cardiology Cases (2011) 4, e163 e167 av ailab le at www.sciencedirect.com jou rn al h om epa g e: www.elsevier.com/locate/jccase Case Report In vivo intravascular ultrasound imaging of fibromuscular
More informationHypertension Update. Aaron J. Friedberg, MD
Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline
More informationDisclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium
Disclosures Vascular Testing in the CLI Patient None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of Vascular Surgery Critical Limb Ischemia Chronic Limb
More informationDIRECT RENIN INHIBITOR (DRI) EFFECT ON GFR AND USE IN RENAL ARTERY STENOSIS SCREENING
DIRECT RENIN INHIBITOR (DRI) EFFECT ON GFR AND USE IN RENAL ARTERY STENOSIS SCREENING Harold Thomas Pretorius, MD, PhD, Nichole Richards, and Michael Harrell Abstract Objective: A new method using a nuclear
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationApproach to patient with hypertension. Dr. Amitesh Aggarwal
Approach to patient with hypertension Dr. Amitesh Aggarwal Definition A systolic blood pressure ( SBP) >139 mmhg and/or A diastolic (DBP) >89 mmhg. Based on the average of two or more properly measured,
More informationRenal Artery FFR. Woo-Young Chung. Seoul National University, College of Medicine Boramae Medical Center Cardiovascular Center
Renal Artery FFR Woo-Young Chung Seoul National University, College of Medicine Boramae Medical Center Cardiovascular Center Why renal FFR? Renal artery angioplasty (PTRA) Indication of Renal artery angioplasty
More informationRenal Intervention. Douglas E. Drachman, MD, FSCAI Division of Cardiology Vascular Medicine Section December 9, 2014
Renal Intervention Douglas E. Drachman, MD, FSCAI Division of Cardiology Vascular Medicine Section December 9, 2014 Disclosure Information Douglas E. Drachman, MD, FACC Abbott Vascular, Inc.: Advisory
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ABI. See Ankle-brachial index (ABI). Afterload, deconstructing of, in ventricular vascular interaction in heart failure, 449 Air plethysmography
More informationHow Low Do We Go? Update on Hypertension
How Low Do We Go? Update on Beth L. Abramson, MD, FRCPC, FACC As presented at the University of Toronto s Saturday at the University Session (September 2003) Arecent World Health Organization report states
More informationIntroduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9
Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...
More informationMetabolic Syndrome and Chronic Kidney Disease
Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference
More informationTread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease
Tread Carefully Because you Tread on my Nephrons Prescribing Hints in Renal Disease David WP Lappin,, MB PhD FRCPI Clinical Lecturer in Medicine and Consultant Nephrologist and General Physician, Merlin
More informationDiabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
More informationSystemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept
Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications
More informationSwindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus 1 Contents Executive Summary... 3 How to Screen for Diabetic Nephropathy... 4 What to Measure... 4 Frequency
More informationThe major issues in approaching patients with renal artery stenosis
Renovascular Hypertension and Ischemic Nephropathy Marc A. Pohl The major issues in approaching patients with renal artery stenosis relate to the role of renal artery stenosis in the management of hypertension,
More informationFibromuscular Dysplasia (FMD) of the renal arteries Angiographic features and therapeutic options
Fibromuscular Dysplasia (FMD) of the renal arteries Angiographic features and therapeutic options Poster No.: C-0630 Congress: ECR 2012 Type: Educational Exhibit Authors: K. I. Ringe, B. Meyer, F. Wacker,
More informationCarotid Stenosis (carotid artery disease)
1 Carotid Stenosis (carotid artery disease) Overview Carotid stenosis is a narrowing of the carotid arteries, the two major arteries that carry oxygenrich blood from the heart to the brain. Also called
More informationTreating Hypertension from
Treating Hypertension from Initiation to Resistance: A Case Study Approach Michelle Krause, MD Division of Nephrology University of Arkansas for Medical Sciences Central Arkansas Veteran s Healthcare System
More informationVA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease
VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERECE CARDS Chronic Kidney Disease CKD VA/DoD Clinical Practice Guideline for the Management
More informationPCI for Renal Artery stenosis
PCI for Renal Artery stenosis Why should we treat Renal Artery Stenosis? Natural History of RAS RAS is progressive disease Study Follow-up (months) Pts Progression N (%) Total occlusion Wollenweber Meaney
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationHypertension and Cardiovascular Disease
Hypertension and Cardiovascular Disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,
More informationSummary of Research and Writing Activities In Cardiovascular Disease
Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts
More informationmajor public health burden
HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationLong-Term Complications of Diabetes Mellitus Macrovascular Complication
Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent
More informationAngioplasty with stent in renal artery stenosis: our experience
Rev Chil Radiol 2016; 22(1): 13-19. Angioplasty with stent in renal artery stenosis: our experience Johanna Marcela Vasquez Veloza *, José Luis Abades Vázquez, José Luis Cordero Castro. Interventional
More informationEvaluation of Colour Duplex Ultrasound Scanning in Diagnosis of Renal Artery Stenosis, Compared to Angiography: A Prospective Study on 53 Patients
Eur J Vasc Endovasc Surg 14, 305-309 (1997) Evaluation of Colour Duplex Ultrasound Scanning in Diagnosis of Renal Artery Stenosis, Compared to Angiography: A Prospective Study on 53 Patients M. Mollo,
More informationA CASE OF HYPERTENSION AND ACUTE RENAL FAILURE OBJECTIVES
A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE Maricel Pilapil-Pureza WLA Nephrology OBJECTIVES After the presentation, the attendee will be able to: 1. Discuss when to suspect for secondary causes of
More informationClinical bene t of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure
Clinical bene t of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure Bruce H Gray a, Jeffrey W Olin b, Mary Beth Childs c, Timothy M Sullivan d
More information